Chunlin Ou

I am working in the department of Pathology, Xiangya Hospital, Central South University. My researches focus on the molecular targeted therapy for human cancers, which mainly involving: 1) The role of Hippo/YAP signaling pathway in targeted therapy of cancers; 2) Exploring the regulatory mechanism of non-coding RNAs in cancers; 3) Searching the novel biomarkers and drug targets for the early diagnosis and therapy of cancers; 4) Clinical application of mRNA vaccine in cancers. As the first author or corresponding author, I have published 47 scientific articles in well-known SCI-indexed journals in the latest five years, such as, Journal of Hematology & Oncology (IF=23.168), Advanced Science (IF=17.521), Theranostics (IF=11.600), International Journal of Biological Sciences (IF=10.750), Cancer letters (IF=9.756) , and Oncogene (IF= 8.756), etc. Furthermore, I am appointed as the Associate Editor of Heliyon (SCI, JCR Q2) and European Journal of Medical Research (SCI, JCR Q2), meanwhile, acted as the Editorial Board member of Frontiers in Bioscience-Landmark, Oncology Research, BMC cancer and Journal of Thoracic Disease, and the contractual reviewer of oncology journals such as Advanced Science, Cancer Treat Rev, and Molecular therapy, etc.